Fortitude Advisory Group L.L.C. Makes New $28,000 Investment in Immutep Limited (NASDAQ:IMMP)

Fortitude Advisory Group L.L.C. purchased a new position in Immutep Limited (NASDAQ:IMMPFree Report) in the fourth quarter, Holdings Channel reports. The fund purchased 12,900 shares of the biotechnology company’s stock, valued at approximately $28,000.

Several other large investors also recently made changes to their positions in IMMP. XTX Topco Ltd acquired a new stake in Immutep in the 2nd quarter worth approximately $26,000. XY Capital Ltd lifted its stake in shares of Immutep by 108.3% in the third quarter. XY Capital Ltd now owns 108,349 shares of the biotechnology company’s stock worth $239,000 after buying an additional 56,344 shares during the last quarter. Finally, Meridian Wealth Management LLC boosted its holdings in shares of Immutep by 4.5% during the 3rd quarter. Meridian Wealth Management LLC now owns 398,450 shares of the biotechnology company’s stock worth $881,000 after buying an additional 17,250 shares during the period. Institutional investors own 2.32% of the company’s stock.

Analyst Ratings Changes

Separately, Robert W. Baird lifted their target price on shares of Immutep from $6.00 to $7.00 and gave the stock an “outperform” rating in a report on Friday, November 15th.

Get Our Latest Analysis on IMMP

Immutep Stock Performance

Shares of IMMP opened at $1.94 on Tuesday. Immutep Limited has a 52 week low of $1.66 and a 52 week high of $3.34. The company has a 50-day simple moving average of $2.03 and a 200-day simple moving average of $2.10. The company has a quick ratio of 18.25, a current ratio of 18.25 and a debt-to-equity ratio of 0.01.

Immutep Company Profile

(Free Report)

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.

See Also

Want to see what other hedge funds are holding IMMP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Immutep Limited (NASDAQ:IMMPFree Report).

Institutional Ownership by Quarter for Immutep (NASDAQ:IMMP)

Receive News & Ratings for Immutep Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immutep and related companies with MarketBeat.com's FREE daily email newsletter.